Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer

Non-small-cell lung cancer (NSCLC) afflicts about 2 million people worldwide, with both genetic (familial) and environmental factors contributing to its development and spread. The inadequacy of currently available therapeutic techniques, such as surgery, chemotherapy, and radiation therapy, in addr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Sona, Roy, Indrajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223242/
https://www.ncbi.nlm.nih.gov/pubmed/37242697
http://dx.doi.org/10.3390/pharmaceutics15051457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223242/
https://www.ncbi.nlm.nih.gov/pubmed/37242697
http://dx.doi.org/10.3390/pharmaceutics15051457

Ejemplares similares